Germany Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Germany Pharmaceuticals and Healthcare Report Q3 2013 Jun 19th 2013, 00:00 BMI View: We remain of the opinion that operating conditions in the German pharmaceutical market will continue to hamper its value development. Over the five years to 2017, we expect a virtual stagnation in the value of the market, which is currently worth in the region of EUR38bn (US$50bn), one of the largest globally. Downward pressures will also be exerted on domestic drugmakers in their target foreign markets, the authorities of which are implementing wide-ranging cost containment measures in a bid to reduce public-sector spending on healthcare. Nevertheless, we believe that volume demand will continue to uphold the development of … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=103165. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/germany-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions